Query billions of fully-integrated lab & health records on more than 325M de-identified patients to answer key healthcare questions in minutes on prognosFACTOR.
In our recent panel discussion “How to determine your next best action for every HCP engagement”, leaders from Novartis, GSK, and Takeda Oncology discussed their #RWD strategies to commercialize drug therapies. 3 important best practices were revealed. prognoshealth.com/blog/provi…
68% of #pharma leaders believe the way #lifescience companies currently purchase patient-level data is ripe for disruption.
Find out what challenges dominate current #RWD efforts and how technology can help address them.
prognoshealth.com/blog/real-…#RealWorldData
In a recent survey of #pharma leaders by Reuters, 68% of respondents believe the way #LifeSciences companies currently purchase patient-level data is ripe for disruption.
Find out what challenges dominate current #RWD efforts and how technology can help.
prognoshealth.com/blog/real-…
Dr. Steven Zatz Joins Prognos Health Board of Directors
"Steve’s vision and leadership helped build WebMD into an iconic healthcare brand," says @sundeepbhan1.
prognoshealth.com/about-us/n…
More than 300M people worldwide are living with a #RareDisease. Every day, Prognos is committed to improving the lives of those impacted.
See how one pharma company helped fight rare disease with RWD analysis: bit.ly/3MdULJA
Let's raise awareness and generate change.
68% of survey respondents believe the way their companies purchase patient-level #data is ripe for disruption. Discover what other peer insights were revealed in the recent Reuters survey of #pharmaceutical leaders. Download the whitepaper to find out. prognoshealth.com/resource/r…
Reuters surveyed pharma professionals to uncover their top 10
challenges when it comes to real-world data processes. The findings? Hint: They all point towards the need for a disruption in the status quo. prognoshealth.com/new-indust…#RWDmarketplace#realworlddata
Results from a new Reuters survey shows a status quo of patient data collection in pharma that is expensive, time-consuming, and ripe for disruption. How do we address these issues? Find out here. prognoshealth.com/resource/r…#RWDmarketplace#realworlddata
Reuters surveyed more than 200 pharmaceutical leaders to determine real-world data (RWD) usage trends for therapy commercialization. What peer insights were revealed? Download the whitepaper to find out. prognoshealth.com/resource/r…#RWDmarketplace#realworlddata
It’s no secret that small & midsize pharma companies don’t have access to the same amount of resources as big pharma. You can level the playing field by utilizing an end-to-end RWD analytics solution. Discover how you can benefit and download the eBook. prognoshealth.com/small-mids…